DRTS Key Statistics, Chart & Performance
The current stock price of DRTS is 6.99 USD. In the past month the price increased by 37.6%. In the past year, price increased by 73.45%.
DRTS Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to DRTS. When comparing the yearly performance of all stocks, DRTS is one of the better performing stocks in the market, outperforming 94.87% of all stocks.
DRTS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to DRTS. DRTS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
DRTS Financial Highlights
Over the last trailing twelve months DRTS reported a non-GAAP Earnings per Share(EPS) of -0.52. The EPS decreased by -20.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.73% | ||
| ROE | -40.64% | ||
| Debt/Equity | 0.07 |
DRTS Forecast & Estimates
10 analysts have analysed DRTS and the average price target is 8.41 USD. This implies a price increase of 20.39% is expected in the next year compared to the current price of 6.99.
DRTS Ownership
About DRTS
Company Profile
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
Company Info
ALPHA TAU MEDICAL LTD
Kiryat Hamada 5
JERUSALEM IL
Employees: 125
Phone: 97235774115
ALPHA TAU MEDICAL LTD / DRTS FAQ
What does DRTS do?
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
What is the current price of DRTS stock?
The current stock price of DRTS is 6.99 USD. The price decreased by -2.51% in the last trading session.
Does DRTS stock pay dividends?
DRTS does not pay a dividend.
What is the ChartMill rating of ALPHA TAU MEDICAL LTD stock?
DRTS has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is ALPHA TAU MEDICAL LTD worth?
ALPHA TAU MEDICAL LTD (DRTS) has a market capitalization of 595.97M USD. This makes DRTS a Small Cap stock.